Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant

Citations Over TimeTop 10% of 2014 papers

Abstract

Synthetic devices for traceless remote control of gene expression may provide new treatment opportunities in future gene- and cell-based therapies. Here we report the design of a synthetic mind-controlled gene switch that enables human brain activities and mental states to wirelessly programme the transgene expression in human cells. An electroencephalography (EEG)-based brain-computer interface (BCI) processing mental state-specific brain waves programs an inductively linked wireless-powered optogenetic implant containing designer cells engineered for near-infrared (NIR) light-adjustable expression of the human glycoprotein SEAP (secreted alkaline phosphatase). The synthetic optogenetic signalling pathway interfacing the BCI with target gene expression consists of an engineered NIR light-activated bacterial diguanylate cyclase (DGCL) producing the orthogonal second messenger cyclic diguanosine monophosphate (c-di-GMP), which triggers the stimulator of interferon genes (STING)-dependent induction of synthetic interferon-β promoters. Humans generating different mental states (biofeedback control, concentration, meditation) can differentially control SEAP production of the designer cells in culture and of subcutaneous wireless-powered optogenetic implants in mice.

Related Papers

• → Biophysical Properties of Optogenetic Tools and Their Application for Vision Restoration Approaches(2016)57 cited
• → A new technique for controlling the brain: optogenetics and its potential for use in research and the clinic(2010)53 cited
• → Optogenetic inhibition of neurons by internal light production(2014)28 cited
• → Optical silencing of C. elegans cells with light-driven proton pumps(2014)10 cited
• → <p>Optogenetic Pacing: Current Insights and Future Potential</p>(2020)